Study: Pricier Malaria Drug Cost-Effective
Posted on: Monday, 9 October 2006, 21:00 CDT
Treating patients with the most expensive anti-malarial drug combination can actually save money in the long run, a new study says.
An evaluation of the three alternative drug combinations now used for the treatment of malaria in Tanzania found that a combination of artemether and lumefantrine, though most expensive in the short run, saved money in the long run because its superior performance in curing malaria reduced the need for further treatment.
Thus, the researchers at the London School of Hygiene and Tropical Medicine say, this combination should be the preferred option for East Africa.
The World Health Organization and other authorities now recommend the use of one of a new type of treatments, based on the Chinese drug artemisinin, combined with an older malaria treatment. The goal is to delay the development of malaria strains that are artemisinin-resistant.
The study, now appearing in the journal PLoS Medicine, is available at the Web site www.plosmedicine.org.
Source: United Press International
Related Articles
- Adamas Pharmaceuticals Expands Clinical Study for Triple-Combination Antiviral Drug Therapy in Immune-Compromised Patients
- Amylin Pharmaceuticals Announces Positive Results from Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment for Obesity
- New Study Shares Benchmarks for Fixed-Dose Combination (FDC) Drug Development
- Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
- Amylin Combination Treatment Found Effective in Obesity Study
- Pramlintide and Leptin Combination Treatment Demonstrates 12.7 Percent Weight Loss in 24-Week Clinical Obesity Study
- Over Half of German Population Favor Combined Treatment of Chinese,Western Medicine
- Stanford Study Evaluates Combined Treatment of Insomnia and Depression
- Combined Treatment of Glioblastoma Patients With Locoregional Pre- Targeted ^Sup 90^Y-Biotin Radioimmunotherapy and Temozolomide
- Report: Beijing Running Out of Drugs
 |
 |
User Comments (0)
RSS Feeds